1UPCR Interpretation — KDIGO Reference Table
| UPCR (mg/mg) | UPCR (mg/g) | KDIGO Category | Est. 24h Excretion | Clinical Significance |
|---|---|---|---|---|
| < 0.15 | < 150 | A1 Normal | < 150 mg/day | Normal physiological urinary protein excretion. |
| 0.15 – 0.50 | 150–500 | A2 Mild | 150–500 mg/day | Moderately elevated; investigate for early diabetic nephropathy or hypertension. |
| 0.50 – 3.50 | 500–3500 | A3 Mod-Severe | 500–3500 mg/day | Significant glomerular or tubular proteinuria; nephrology referral warranted. |
| > 3.50 | > 3500 | Nephrotic Range | > 3500 mg/day | Nephrotic-range proteinuria; urgent specialist nephrology workup. |
2Clinical Reference Guide & Formula
The Urine Protein-to-Creatinine Ratio (UPCR) corrects for variations in urine dilution by dividing urinary protein concentration by urinary creatinine concentration. Because renal creatinine excretion is relatively constant over 24 hours, UPCR from a spot sample (ideally a first morning void) correlates exceptionally well with 24-hour urine protein collection ($r > 0.9$).
Why UPCR Instead of 24-Hour Urine Collection?
24-hour urine collection is inconvenient for patients and frequently inaccurate due to incomplete or improperly timed collection. UPCR from a spot urine specimen — ideally a first morning void to avoid postural (orthostatic) proteinuria — correlates well with 24-hour urinary protein excretion (r >0.9 in most studies). KDIGO 2012 guidelines recommend UPCR or ACR (albumin-creatinine ratio) as the standard for proteinuria quantification in chronic kidney disease.
Causes of Elevated UPCR
- Glomerular proteinuria: Diabetic nephropathy, IgA nephropathy, membranous nephropathy, FSGS, lupus nephritis, amyloidosis — typically high UPCR, may reach nephrotic range
- Tubular proteinuria: Acute kidney injury, Fanconi syndrome, heavy metal toxicity — low molecular weight proteins, UPCR typically <1.5
- Overflow proteinuria: Multiple myeloma (Bence-Jones proteins), haemoglobinuria, myoglobinuria — standard urine dipstick may miss Bence-Jones protein
- Transient or benign: Fever, vigorous exercise, orthostatic (postural) proteinuria — check a first morning void sample to exclude this
3UPCR vs. UACR — Which Test to Choose?
| Diagnostic Feature | UPCR (Protein:Creatinine) | UACR (Albumin:Creatinine) |
|---|---|---|
| Analyte Target | Total urinary protein (Albumin + globulins + tubular proteins) | Albumin exclusively |
| Primary Clinical Utility | Quantifying heavy proteinuria and non-diabetic glomerular CKD. | Screening early diabetic nephropathy and microalbuminuria (>30 mg/g). |
| Tubular / Overflow Detection | Yes (detects Bence-Jones / tubular proteins) | No (misses non-albumin proteins) |
Sources of Error in UPCR
False high UPCR: blood contamination (menstruation, haematuria), urinary tract infection (Tamm-Horsfall protein, pyuria), very concentrated urine. False low UPCR: very dilute urine from high fluid intake. Postural (orthostatic) proteinuria is common in adolescents — UPCR is elevated when upright but normal on a recumbent first morning void sample. Bence-Jones proteinuria in multiple myeloma is often missed by standard urine dipstick and requires urine protein electrophoresis (UPEP) for detection.
UPCR in CKD Staging — KDIGO 2024
KDIGO 2024 CKD classification combines an albuminuria category (A1/A2/A3) with the eGFR stage (G1–G5) to assess prognosis. UACR <30 mg/g = A1 (normal/mild). UACR 30–300 mg/g = A2 (moderately increased). UACR >300 mg/g = A3 (severely increased). A worsening albuminuria category indicates CKD progression and should prompt nephrology referral and treatment escalation.
Managing Proteinuria in CKD
First-line: ACE inhibitors (ramipril, enalapril) or ARBs (losartan, telmisartan) reduce intraglomerular pressure and proteinuria by 30–50%, slowing CKD progression. Target blood pressure <130/80 mmHg. SGLT2 inhibitors (empagliflozin, dapagliflozin) provide additional renoprotection in proteinuric CKD independent of diabetes status. Finerenone, a mineralocorticoid receptor antagonist, further reduces CKD progression in type 2 diabetes with UACR ≥30 mg/g. NSAIDs, nephrotoxic drugs, and iodinated contrast should be avoided in proteinuric CKD wherever possible.